This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Flowers, L. C. Articles by Gazdar, A. F. Search for Related Content PubMed PubMed Citation Articles by Flowers, L. C. Articles by Wistuba, I. I. Articles by Scurry, J. Articles by Muller, C. Y. Articles by Ashfaq, R. Articles by Miller, D. S. Articles by Minna, J. D. Articles by Gazdar, A. F. Social Bookmarking                         What's this?

Genetic Changes During the Multistage Pathogenesis of Human Papiloomavirus Positive and Negative Vulvar Carcinomas

Ignacio I. Wistuba, MD

James Scurry, MD

Carolyn Y. Muller, MD

Raheela Ashfaq, MD

David S. Miller, MD

John D. Minna, MD

Hamon Center for Therapeutic Oncology Research, Departments of Obsterics and Gynecology, Pathology, Internal Medicine, and Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas: and Department of Pathology, Mercy Hospital for women, Melbourne, Australia

Adi F. Gazdar, MD

Hamon Center for Therapeutic Oncology Research, Departments of Obsterics and Gynecology, Pathology, Internal Medicine, and Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas: and Department of Pathology, Mercy Hospital for women, Melbourne, Australia; gazdar{at}simmons.swmed.edu

Objective: To identify the molecular alterations found in 30 human papillomavirus (HPV) positive (n = 15) and negative (n = 15) vulvar carcinomas (VC) and their associated preinasive lesions (VIN [valvar intraepithelial neoplaisa]) and normal epithelium to determine a common molecular pathogenesis of HPV positive and negative VC.

Methods: Loss of heterozygosity (LOH) at seven 3p chromosomal regions (3p12, 3p14.2, 2p14.3-21.1, 3p21.3, 3p22-24, 3p24.3, 3p25), 13p14 (RB) and 17p13.1 (p53) loci, and TP53 gene mutations in microdissected archival tissues were investigated.

Results: Fourteen of fifteen HPV positive VC had HPN 16DNA sequences. The fractional regional loss index (FRL), an index of total allelic loss at all chromosomal regions analyzed, was greater in the HPV negative VCs than in the HPV positive tumors (FRL = 0.55 versus 0.32; P = .048) and was also greate in the HPV negative high-grade VINs as compared with the HPV positive lesions (0.29 versus 0.02; P = .002). Overall, LOH at any 3p region was frequent (80%) in both groups of cancer and in their associated VIN lesions. Although TP53 gene mutations were present in a minority of VCs (20%), allelic losses at the TP53 locus were ferquently present, especially in HPV negative VCs, as compared with the HPV positive tumors (62% versus 15%; P = .02).

Conclusion: A greater number of molecular alterations are found in HPV negative VCs compred with HPV positive tumors. Allelic losses at 3p are common early events in vulvar carcinogenesis in HPV negative cancer detected at a high rate in the corresponding high-grade precursor lesions (VIN II/III). TP53 gene mutations with associated 17p13.1 LOH are more common in HPV negative cancers.

Key Words: Loss of heterozygosity • chromosome 3p • human papillomavirus • vulvar cancer

Journal of the Society for Gynecologic Investigation, Vol. 6, No. 4, 213-221 (1999)
DOI: 10.1177/107155769900600409


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?